6月30日中欧医疗创新股票A净值增长1.60%，今年来累计上涨32.25%

Group 1 - The core viewpoint of the article highlights the performance of the China Europe Medical Innovation Stock A fund, which has shown significant growth in recent months and year-to-date [1] - As of June 30, 2025, the latest net value of the fund is 1.3751 yuan, reflecting a growth of 1.60% [1] - The fund's one-month return is 3.33%, six-month return is 32.25%, and year-to-date return is also 32.25%, with respective rankings of 276 out of 1029, 29 out of 997, and 30 out of 997 in its category [1] Group 2 - The top ten holdings of the China Europe Medical Innovation Stock A fund account for a total of 75.62%, with major investments in companies such as WuXi AppTec (10.35%), Kelun-Biotech (10.15%), and WuXi Biologics (9.82%) [1] - The fund was established on February 28, 2019, and as of March 31, 2025, it has a total scale of 4.675 billion yuan [1] - The fund manager, Ms. Ge Lan, has a background in biomedical engineering and has held various positions in research and fund management since joining China Europe Fund Management in 2014 [2]